Gulf Times - Glenmark
India's Glenmark to study potential Covid-19 drug combination

India's Glenmark to study potential Covid-19 drug combination

Glenmark Pharmaceuticals Ltd said on Tuesday it will begin a new clinical trial in India to test a combination of two anti-viral drugs, favipiravir and umifenovir, as a potential Covid-19 treatment.